Figure 3
Figure 3. Effect of scFv/uPA-T on circulating RBCs and its organ distribution in vivo. (A) Distribution of radioactivity in mice after administration of 51Cr-labeled mouse RBCs followed by the intravenous injection of 4mg/kg scFv/uPA-T or PBS. The animals were killed 1 hour (supplemental Figure 3) or 6 hours (panel A) later and 51Cr was measured in the blood and major peripheral organs (n = 4). The inset indicates 51Cr distribution between blood plasma and cells at the indicated times. (B) Distribution of 125I-labeled scFv/uPA-T in organs at the indicated times after intravenous injection in mice. Inset: Distribution of 125I-scFv/uPA-T between blood plasma and cells (n = 5).

Effect of scFv/uPA-T on circulating RBCs and its organ distribution in vivo. (A) Distribution of radioactivity in mice after administration of 51Cr-labeled mouse RBCs followed by the intravenous injection of 4mg/kg scFv/uPA-T or PBS. The animals were killed 1 hour (supplemental Figure 3) or 6 hours (panel A) later and 51Cr was measured in the blood and major peripheral organs (n = 4). The inset indicates 51Cr distribution between blood plasma and cells at the indicated times. (B) Distribution of 125I-labeled scFv/uPA-T in organs at the indicated times after intravenous injection in mice. Inset: Distribution of 125I-scFv/uPA-T between blood plasma and cells (n = 5).

Close Modal

or Create an Account

Close Modal
Close Modal